The DOI matches its Crossref record; 671 of the 671 references it cites were found in a registry or an index.
Sustained proliferation in cancer: Mechanisms and novel therapeutic targets
Open accessAbstract
Proliferation is an important part of cancer development and progression. This is manifest by altered expression and/or activity of cell cycle related proteins. Constitutive activation of many signal transduction pathways also stimulates cell growth. Early steps in tumor development are associated with a fibrogenic response and the development of a hypoxic environment which favors the survival and proliferation of cancer stem cells. Part of the survival strategy of cancer stem cells may manifested by alterations in cell metabolism. Once tumors appear, growth and metastasis may be supported by overproduction of appropriate hormones (in hormonally dependent cancers), by promoting angiogenesis, by undergoing epithelial to mesenchymal transition, by triggering autophagy, and by taking cues from surrounding stromal cells. A number of natural compounds (e.g., curcumin, resveratrol, indole-3-carbinol, brassinin, sulforaphane, epigallocatechin-3-gallate, genistein, ellagitannins, lycopene and quercetin) have been found to inhibit one or more pathways that contribute to proliferation (e.g., hypoxia inducible factor 1, nuclear factor kappa B, phosphoinositide 3 kinase/Akt, insulin-like growth factor receptor 1, Wnt, cell cycle associated proteins, as well as androgen and estrogen receptor signaling). These data, in combination with bioinformatics analyses, will be very important for identifying signaling pathways and molecular targets that may provide early diagnostic markers and/or critical targets for the development of new drugs or drug combinations that block tumor formation and progression.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
7 retracted
Items 401–600 of 671
Promoter demethylation of WIF-1 by epigallocatechin-3-gallate in lung cancer cells.
Gao, Z., Xu, Z., Hung, M., Lin, Y., Wang, T., Gong, M., Zhi, X., Jablon, D. M., & You, L. (2009) · PubMed · Cited by 123
Desmethylclomipramine induces the accumulation of autophagy markers by blocking autophagic flux
Rossi, M., Munarriz, E. R., Bartesaghi, S., Milanese, M., Dinsdale, D. D., Martin, M. G., Bampton, E. T. W., Glynn, P., Bonanno, G., Knight, R. A., et al. (2009) · Journal of Cell Science · doi:10.1242/jcs.048181 · Cited by 123
Hypoxia inducible factor-2α: a critical mediator of aggressive tumor phenotypes
Qing, G., & Simon, M. C. (2009) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2008.12.001 · Cited by 122
Hypoxia-inducible factors: crosstalk between inflammation and metabolism
Shay, J. E. S., & Celeste Simon, M. (2012) · Seminars in Cell & Developmental Biology · doi:10.1016/j.semcdb.2012.04.004 · Cited by 122
Saud, S. M., Li, W., Morris, N. L., Matter, M. S., Colburn, N. H., Kim, Y. S., & Young, M. R. (2014) · Carcinogenesis · doi:10.1093/carcin/bgu209 · Cited by 122
Shukla, S., MacLennan, G. T., Flask, C. A., Fu, P., Mishra, A., Resnick, M. I., & Gupta, S. (2007) · Cancer Research · doi:10.1158/0008-5472.can-07-0717 · Cited by 122
Nishi, M., Sakai, Y., Akutsu, H., Nagashima, Y., Quinn, G., Masui, S., Kimura, H., Perrem, K., Umezawa, A., Yamamoto, N., et al. (2013) · Oncogene · doi:10.1038/onc.2012.614 · Cited by 121
Lycopene inhibits TNF-α-induced endothelial ICAM-1 expression and monocyte-endothelial adhesion
Hung, C., Huang, T., Chen, B., Shieh, J., Wu, P., & Wu, W. (2008) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2008.03.001 · Cited by 121
Fan, Y., Dickman, K. G., & Zong, W. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.035584 · Cited by 120
The β-catenin/TCF complex as a novel target of resveratrol in the Wnt/β-catenin signaling pathway
Chen, H., Hsu, L.-S., Shia, Y.-T., Lin, M., & Lin, C.-M. (2012) · Biochemical Pharmacology · doi:10.1016/j.bcp.2012.08.011 · Cited by 120
Gomez, L. S., Zancan, P., Marcondes, M. C., Ramos-Santos, L., Meyer‐Fernandes, J. R., Sola‐Penna, M., & Silva, D. (2013) · Biochimie · doi:10.1016/j.biochi.2013.02.013 · Cited by 120
Regulation of Akt/FOXO3a/GSK-3β/AR Signaling Network by Isoflavone in Prostate Cancer Cells
Li, Y., Wang, Z. P., Kong, D., Li, R., Sarkar, S. H., & Sarkar, F. H. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m802759200 · Cited by 120
Nagahata, T., Shimada, T., Harada, A., Nagai, H., Onda, M., Yokoyama, S., Shiba, T., Jin, E., Kawanami, O., & Emi, M. (2003) · Cancer Science · doi:10.1111/j.1349-7006.2003.tb01475.x · Cited by 120
Autophagy, Bafilomycin and Cell Death: The “A-B-Cs” of Plecomacrolide-Induced Neuroprotection
Shacka, J. J., Klocke, B. J., & Roth, K. A. (2006) · Autophagy · doi:10.4161/auto.2703 · Cited by 120
Su, Y., & Simmen, F. A. (2008) · Carcinogenesis · doi:10.1093/carcin/bgn279 · Cited by 119
Role of ERβ palmitoylation in the inhibition of human colon cancer cell proliferation
Galluzzo, P., Caiazza, F., Moreno, S., & Marino, M. (2007) · Endocrine Related Cancer · doi:10.1677/erc-06-0020 · Cited by 119
Self-citationBiphasic Estradiol-induced AKT Phosphorylation Is Modulated by PTEN via MAP Kinase in HepG2 Cells
Marino, M., Acconcia, F., & Trentalance, A. (2003) · Molecular Biology of the Cell · doi:10.1091/mbc.e02-09-0621 · Cited by 119
Self-citationHe, X., Wang, Y., Zhu, J., Orloff, M. S., & Eng, C. (2010) · Cancer Letters · doi:10.1016/j.canlet.2010.11.012 · Cited by 118
Ignored Hallmarks of Carcinogenesis: Stem Cells and Cell‐Cell Communication
Trosko, J. E., CHANG, C., Upham, B. L., & TAI, M. (2004) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1322.023 · Cited by 118
Stromal Estrogen Receptor-α Promotes Tumor Growth by Normalizing an Increased Angiogenesis
Péqueux, C., Raymond‐Letron, I., Blacher, S., Boudou, F., Adlanmérini, M., Fouque, M.-J., Rochaix, P., Noël, A., Foidart, J.-M., Krust, A., et al. (2012) · Cancer Research · doi:10.1158/0008-5472.can-11-3768 · Cited by 118
EF24, a novel curcumin analog, disrupts the microtubule cytoskeleton and inhibits HIF-1
Thomas, S. L., Zhong, D., Zhou, W., Malik, S., Liotta, D. C., Snyder, J. P., Hamel, E., & Giannakakou, P. (2008) · Cell Cycle · doi:10.4161/cc.6410 · Cited by 117
Resveratrol-induced apoptosis in human T-cell acute lymphoblastic leukaemia MOLT-4 cells
Cecchinato, V., Chiaramonte, R., Nizzardo, M., Cristofaro, B., Basile, A., Sherbet, G. V., & Comi, P. (2007) · Biochemical Pharmacology · doi:10.1016/j.bcp.2007.08.001 · Cited by 117
Zhang, J., Fukuhara, S., Sako, K., Takenouchi, T., Kitani, H., Kume, T., Koh, G. Y., & Mochizuki, N. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.192641 · Cited by 117
Zeuner, A., Francescangeli, F., Contavalli, P., Zapparelli, G., Apuzzo, T., Eramo, A., Baiocchi, M., Angelis, M. L. D., Biffoni, M., Sette, G., et al. (2014) · Cell Death and Differentiation · doi:10.1038/cdd.2014.105 · Cited by 117
Holy, J. (2002) · Mutation research · doi:10.1016/s1383-5718(02)00076-1 · Cited by 117
Yan, C., Jamaluddin, M. S., Aggarwal, B. B., Myers, J. N., & Boyd, D. D. (2005) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.233.4.2 · Cited by 117
Zhang, X., Yin, W., Shi, X.-D., & Li, Y. (2011) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2011.02.009 · Cited by 116
Martelli, A. M., Evangelisti, C., Follo, M., Ramazzotti, G., Fini, M., Giardino, R., Manzoli, L., McCubrey, J. A., & Cocco, L. (2011) · Current Medicinal Chemistry · doi:10.2174/092986711796011201 · Cited by 116
Qi, W., Weber, C. R., Wasland, K., & Savkovic, S. D. (2011) · BMC Cancer · doi:10.1186/1471-2407-11-219 · Cited by 115
Activated macrophages induce metastatic behavior of colon cancer cells
Jedinak, A., Dudhgaonkar, S. P., & Slíva, D. (2009) · Immunobiology · doi:10.1016/j.imbio.2009.03.004 · Cited by 114
Colorectal cancer chemoprevention by trans-resveratrol
Juan, M. E., Alfaras, I., & Planas, J. M. (2012) · Pharmacological Research · doi:10.1016/j.phrs.2012.03.010 · Cited by 113
Sethi, G., Ahn, K. S., Sandur, S. K., Lin, X., Chaturvedi, M. M., & Aggarwal, B. B. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m602627200 · Cited by 113
Dey, P., Ström, A., & Gustafsson, J.-Å. (2013) · Oncogene · doi:10.1038/onc.2013.384 · Cited by 113
Pérez-Mancera, P. A., González‐Herrero, I., Pérez-Caro, M., Gutiérrez-Cianca, N., Flores, T., Gutiérrez‐Adán, A., Pintado, B., Sánchez‐Martín, M., & Sánchez-García, I. (2005) · Oncogene · doi:10.1038/sj.onc.1208505 · Cited by 110
Chen, A., & Zheng, S. (2007) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0707542 · Cited by 110
Ye, M.-X., Zhao, Y., Li, Y., Miao, Q., Li, Z., Ren, X., Song, L., Yin, H., & Zhang, J. (2012) · Phytomedicine · doi:10.1016/j.phymed.2012.03.005 · Cited by 109
Wang, Y., Romigh, T., He, X., Orloff, M. S., Silverman, R. H., Heston, W. D. W., & Eng, C. (2010) · Human Molecular Genetics · doi:10.1093/hmg/ddq354 · Cited by 109
Smith, S. C., Baras, A. S., Lee, J. K., & Theodorescu, D. (2010) · Cancer Research · doi:10.1158/0008-5472.can-09-3562 · Cited by 108
A Glycine N-methyltransferase Knockout Mouse Model for Humans with Deficiency of this Enzyme
Luka, Z., Capdevila, A., Mato, J. M., & Wagner, C. (2006) · Transgenic Research · doi:10.1007/s11248-006-0008-1 · Cited by 107
Beneficial effects of combining nilotinib and imatinib in preclinical models of BCR-ABL+ leukemias
Weisberg, E., Catley, L., Wright, R. D., Moreno, D., Banerji, L., Ray, A., Manley, P. W., Mestan, J., Fabbro, D., Jiang, J., et al. (2006) · Blood · doi:10.1182/blood-2006-06-026377 · Cited by 107
Jagadeesh, S., Kyo, S., & Banerjee, P. P. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-2494 · Cited by 107
Sotoca, A. M., Ratman, D., van der Saag, P. T., Ström, A., Gustafsson, J. A., Vervoort, J. J. M., Rietjens, I. M. C. M., & Murk, A. J. (2008) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2008.10.002 · Cited by 107
Azios, N. G., Krishnamoorthy, L., Harris, M., Cubano, L. A., Cammer, M., & Dharmawardhane, S. F. (2007) · Neoplasia · doi:10.1593/neo.06778 · Cited by 104
Resveratrol downregulates Akt/GSK and ERK signalling pathways in OVCAR-3 ovarian cancer cells
Vergara, D., Simeone, P., Toraldo, D., Boccio, P. D., Vergaro, V., Leporatti, S., Pieragostino, D., Tinelli, A., Domenico, S. D., Alberti, S., et al. (2012) · Molecular BioSystems · doi:10.1039/c2mb05486h · Cited by 104
Büchler, P., Reber, H. A., Büchler, M. W., Frieß, H., Lavey, R. S., & Hines, O. J. (2003) · Cancer · doi:10.1002/cncr.11873 · Cited by 104
Targeting the Akt Kinase to Modulate Survival, Invasiveness and Drug Resistance of Cancer Cells
Cassinelli, G., Zuco, V., Gatti, L., Lanzi, C., Zaffaroni, N., Colombo, D., & Perego, P. (2013) · Current Medicinal Chemistry · doi:10.2174/09298673113209990106 · Cited by 104
The Expanding Role of Cell Cycle Regulators
Jacks, T., & Weinberg, R. A. (1998) · Science · doi:10.1126/science.280.5366.1035 · Cited by 103
Function of oncogenes in cancer development: a changing paradigm
Vicente‐Dueñas, C., Romero-Camarero, I., Cobaleda, C., & Sánchez-García, I. (2013) · The EMBO Journal · doi:10.1038/emboj.2013.97 · Cited by 103
Resveratrol down-regulates the growth and telomerase activity of breast cancer cells in vitro
Lanzilli, G., Fuggetta, M. P., Tricarico, M., Cottarelli, A., Serafino, A., Falchetti, R., Ravagnan, G., Turriziani, M., Adamo, R., Franzese, O., et al. (2006) · International Journal of Oncology · doi:10.3892/ijo.28.3.641 · Cited by 103
Trung, L. Q., Espinoza, J. L., Takami, A., & Nakao, S. (2013) · PLoS ONE · doi:10.1371/journal.pone.0055183 · Cited by 102
Wickenden, J. A., & Watson, C. J. (2010) · Breast Cancer Research · doi:10.1186/bcr2558 · Cited by 102
Direct reprogramming by oncogenic Ras and Myc
Ischenko, I., Zhi, J., Moll, U. M., Nemajerová, A., & Petrenko, O. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1219592110 · Cited by 102
Control of cell proliferation in atherosclerosis: insights from animal models and human studies
Fuster, J. J., Fernandez, P., Navarro, H. G., Silvestre, C., Nabah, Y. N. A., & Andrés, V. (2009) · Cardiovascular Research · doi:10.1093/cvr/cvp363 · Cited by 102
Ikegawa, T., Ushigome, F., Koyabu, N., et al. (2000) · Cancer Letters · doi:10.1016/s0304-3835(00)00549-8 · Cited by 101
Mimeault, M., & Batra, S. K. (2007) · Annals of Oncology · doi:10.1093/annonc/mdm070 · Cited by 101
Dai, W., Wang, F., He, L., Lin, C., Wu, S.-M., Chen, P., Zhang, Y., Shen, M., Wu, D., Wang, C., et al. (2013) · Molecular Carcinogenesis · doi:10.1002/mc.22100 · Cited by 100
Cloonan, S. M., & Williams, D. C. (2010) · International Journal of Cancer · doi:10.1002/ijc.25477 · Cited by 98
Signaling pathways in breast cancer: Therapeutic targeting of the microenvironment
Kamdje, A. H. N., Etet, P. F. S., Vecchio, L., Jm, M., Krampera, M., & Lukong, K. E. (2014) · Cellular Signalling · doi:10.1016/j.cellsig.2014.07.034 · Cited by 98
Catalano, A., Rodilossi, S., Rippo, M. R., Caprari, P., & Procopio, A. D. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m406696200 · Cited by 97
Metastasis Awakening: Targeting dormant cancer
Aguirre‐Ghiso, J. A., Bragado, P., & Sosa, M. S. (2013) · Nature Medicine · doi:10.1038/nm.3120 · Cited by 97
Hendrayani, S., Al‐Khalaf, H. H., & Aboussekhra, A. (2013) · Neoplasia · doi:10.1593/neo.13478 · Cited by 96
Acconcia, F., & Marino, M. (2011) · Frontiers in Physiology · doi:10.3389/fphys.2011.00030 · Cited by 96
Self-citationS–Adenosylmethionine Regulates Cytoplasmic HuR Via AMP–Activated Kinase
Martínez‐Chantar, M. L., Vázquez–Chantada, M., Garnacho, M., Latasa, M. U., Varela‐Rey, M., Dotor, J., Santamaria, M., Martínez‐Cruz, L. A., Parada, L. A., Lu, S. C.-L., et al. (2006) · Gastroenterology · doi:10.1053/j.gastro.2006.04.019 · Cited by 96
Kinsell, L. W., Harper, H. A., Barton, H. C., Michaels, G. D., & Weiss, H. A. (1947) · Science · doi:10.1126/science.106.2763.589 · Cited by 96
Pons, D. G., Nadal‐Serrano, M., Blanquer-Rosselló, M. D. M., Sastre‐Serra, J., Oliver, J., & Roca, P. (2013) · Journal of Cellular Biochemistry · doi:10.1002/jcb.24737 · Cited by 95
Li, Y., Liu, J., Liu, X., Xing, K., Wang, Y., Li, F., & Yao, L. (2006) · Applied Biochemistry and Biotechnology · doi:10.1385/abab:135:3:181 · Cited by 95
Larriba, M. J., Valle, N., Pálmer, H. G., Ordóñez‐Morán, P., Álvarez-Díaz, S., Becker, K., Gamallo, C., de Herreros, A. G., González‐Sancho, J. M., & Múñoz, A. (2007) · Endocrine Related Cancer · doi:10.1677/erc-06-0028 · Cited by 95
A role for hypoxia and hypoxia-inducible transcription factors in tumor physiology
Acker, T., & Plate, K. H. (2002) · Journal of Molecular Medicine · doi:10.1007/s00109-002-0355-1 · Cited by 95
IR/IGF1R signaling as potential target for treatment of high-grade osteosarcoma
Kuijjer, M. L., Peterse, E. F. P., van den Akker, B. E., Bruijn, I. H. B., Serra, M., Meza‐Zepeda, L. A., Myklebost, O., Hassan, A. B., Hogendoorn, P. C. W., & Cleton-Jansen, A. (2013) · BMC Cancer · doi:10.1186/1471-2407-13-245 · Cited by 95
Bitter Melon: Antagonist to Cancer
Nerurkar, P. V., & Ray, R. B. (2010) · Pharmaceutical Research · doi:10.1007/s11095-010-0057-2 · Cited by 94
On the role of Wnt/β-catenin signaling in stem cells
Kühl, S. J., & Kühl, M. (2012) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2012.08.010 · Cited by 94
Wang, L., Guo, H., Yang, L., Dong, L., Lin, C., Zhang, J., Lin, P., & Wang, X. (2013) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-013-1621-y · Cited by 93
Sachdev, D., Zhang, X., Matise, I., Gaillard-Kelly, M., & Yee, D. (2009) · Oncogene · doi:10.1038/onc.2009.316 · Cited by 93
Wolanin, K., Magalska, A., Mosieniak, G., Klinger, R. W., McKenna, S. L., Vejda, S., Sikora, E., & Piwocka, K. (2006) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-05-0172 · Cited by 93
Metastatic cancer stem cells: from the concept to therapeutics.
Liao, W., Ye, Y., Deng, Y., Bian, X., & Ding, Y.-Q. (2014) · Europe PMC (PubMed Central) · Cited by 92
Sending the right signal: Notch and stem cells
Perdigoto, C. N., & Bardin, A. J. (2012) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2012.08.009 · Cited by 92
Resveratrol suppresses hepatoma cell invasion independently of its anti-proliferative action
Kozuki, Y., Miura, Y., & Yagasaki, K. (2001) · Cancer Letters · doi:10.1016/s0304-3835(01)00476-1 · Cited by 92
Sun, C., Hu, Y., Liu, X., Wu, T., Wang, Y., He, W., & Wenning, W. (2006) · Cancer Genetics and Cytogenetics · doi:10.1016/j.cancergencyto.2005.06.016 · Cited by 92
Khuda‐Bukhsh, A. R., Das, S., & Saha, S. K. (2013) · Nutrition and Cancer · doi:10.1080/01635581.2014.864420 · Cited by 91
Resveratrol inhibits proliferation, angiogenesis and induces apoptosis in colon cancer cells
Fouad, M. A., Agha, A., Merzabani, M. A., & Shouman, S. A. (2013) · Human & Experimental Toxicology · doi:10.1177/0960327113475679 · Cited by 91
Chen, L., & Khillan, J. S. (2009) · Stem Cells · doi:10.1002/stem.251 · Cited by 90
Narayanan, B. A. (2006) · Current Cancer Drug Targets · doi:10.2174/156800906779010218 · Cited by 90
Parekh, P. R., Motiwale, L., Naik, N. R., & Rao, K. V. K. (2010) · Experimental and Toxicologic Pathology · doi:10.1016/j.etp.2009.11.005 · Cited by 89
Qazi, A. M., Pal, J., Maitah, M. Y., et al. (2010) · Translational Oncology · doi:10.1593/tlo.10235 · Cited by 88
Myoung, H., Hong, S., Yun, P., Lee, J., & Kim, M. (2003) · Cancer Science · doi:10.1111/j.1349-7006.2003.tb01422.x · Cited by 88
Androgen Depletion Induces Senescence in Prostate Cancer Cells through Down-regulation of Skp2
Pernicová, Z., Slabáková, E., Kharaishvili, G., Bouchal, J., Král, M., Kunická, Z., Machala, M., Kozubík, A., & Souček, K. (2011) · Neoplasia · doi:10.1593/neo.11182 · Cited by 87
Xu, Y., Zhang, J., Han, J., et al. (2012) · Molecular Oncology · doi:10.1016/j.molonc.2012.03.005 · Cited by 87
Genistein alters growth factor signaling in transgenic prostate model (TRAMP)
Wang, J., Eltoum, I.-E. A., & Lamartiniere, C. A. (2004) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2003.12.018 · Cited by 87
Effect of resveratrol on proliferation and telomerase activity of human colon cancer cells in vitro.
Fuggetta, M. P., Lanzilli, G., Tricarico, M., Cottarelli, A., Falchetti, R., Ravagnan, G., & Bonmassar, E. (2006) · PubMed · Cited by 86
Marino, M., & Ascenzi, P. (2008) · Steroids · doi:10.1016/j.steroids.2007.12.003 · Cited by 86
Self-citationNarayanan, B. A., Narayanan, N. K., Desai, D. H., Pittman, B. P., & Reddy, B. S. (2004) · Carcinogenesis · doi:10.1093/carcin/bgh252 · Cited by 86
The dawn of hedgehog inhibitors: Vismodegib
Selvarajan, S., Melvin, G., Kumar, S. S., & Dkhar, S. A. (2013) · Journal of Pharmacology and Pharmacotherapeutics · doi:10.4103/0976-500x.107628 · Cited by 86
Resveratrol inhibits migration and invasion of human breast‐cancer cells
Tang, F., Su, Y., Chen, N., Hsieh, H., & Chen, K. (2008) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.200700325 · Cited by 86
Wu, H., Liang, X., Fang, Y., Qin, X., Zhang, Y., & Liu, J. (2008) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2008.06.036 · Cited by 86
Zhang, Y., Li, Q., Zhou, D., & Chen, H. (2012) · British Journal Of Nutrition · doi:10.1017/s0007114512000876 · Cited by 85
PI3K Functions in Cancer Progression, Anticancer Immunity and Immune Evasion by Tumors
Dituri, F., Mazzocca, A., Giannelli, G., & Antonaci, S. (2011) · Clinical and Developmental Immunology · doi:10.1155/2011/947858 · Cited by 84
Martinez‐Outschoorn, U., Curry, J., Ko, Y., Lin, Z., Tuluc, M., Cognetti, D. M., Birbe, R., Pribitkin, E. A., Bombonati, A., Pestell, R. G., et al. (2013) · Cell Cycle · doi:10.4161/cc.25510 · Cited by 83
EGF signalling pathway regulates colon cancer stem cell proliferation and apoptosis
Feng, Y., Dai, X., Li, X., Wang, H., Liu, J., Zhang, J., Du, Y., & Xia, L. (2012) · Cell Proliferation · doi:10.1111/j.1365-2184.2012.00837.x · Cited by 83
Mailander, P. C., Meza, J. L., Higginbotham, S. M., & Chakravarti, D. (2006) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2006.06.019 · Cited by 83
Bishayee, A., Waghray, A., Barnes, K. F., Mbimba, T., Bhatia, D., Chatterjee, M., & Darvesh, A. S. (2010) · Pharmaceutical Research · doi:10.1007/s11095-010-0144-4 · Cited by 82
3,3′-Diindolylmethane inhibits breast cancer cell growth via miR-21-mediated Cdc25A degradation
Jin, Y. (2011) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-011-0985-0 · Cited by 82
Examining the Role of Cyclin D1 in Breast Cancer
Velasco-Velázquez, M. A., Li, Z., Casimiro, M. C., Loro, E., Homsi, N., & Pestell, R. G. (2011) · Future Oncology · doi:10.2217/fon.11.56 · Cited by 81
Xia, Y., Jin, L., Zhang, B., Xue, H., Li, Q., & Xu, Y. (2007) · Life Sciences · doi:10.1016/j.lfs.2007.04.008 · Cited by 81
Genistein attenuates WNT signaling by up-regulating sFRP2 in a human colon cancer cell line
Zhang, Y., & Chen, H. (2011) · Experimental Biology and Medicine · doi:10.1258/ebm.2011.010347 · Cited by 81
The pro‐apoptotic effect of quercetin in cancer cell lines requires ERβ‐dependent signals
Bulzomi, P., Galluzzo, P., Bolli, A., Leone, S., Acconcia, F., & Marino, M. (2011) · Journal of Cellular Physiology · doi:10.1002/jcp.22917 · Cited by 81
Self-citationWu, W. (1992) · International Journal of Oncology · doi:10.3892/ijo_00000073 · Cited by 81
Rao, C. V., Cooma, I., Rodriguez, J. G. R., Simi, B., El‐Bayoumy, K., & Reddy, B. S. (2000) · Carcinogenesis · doi:10.1093/carcin/21.4.617 · Cited by 80
Wen, X., Wu, S., Li, Z., Liu, Z., Zhang, J., Wang, G., Jiang, Z., & Wu, S. (2009) · Phytotherapy Research · doi:10.1002/ptr.2616 · Cited by 80
Galluzzo, P., Martini, C., Bulzomi, P., Leone, S., Bolli, A., Pallottini, V., & Marino, M. (2009) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.200800239 · Cited by 80
Self-citationPratt, M. A. C., Tibbo, E., Robertson, S., Jansson, D., Hurst, K., Perez‐Iratxeta, C., Lau, R., & Niu, M. Y. (2009) · Oncogene · doi:10.1038/onc.2009.131 · Cited by 79
Mo, W., Xu, X., Xu, L., Wang, F., Ke, A., Wang, X., & Guo, C. (2011) · Pancreatology · doi:10.1159/000333542 · Cited by 79
Wray, J. P., & Hartmann, C. (2011) · Trends in Cell Biology · doi:10.1016/j.tcb.2011.11.004 · Cited by 79
DNA methylation and histone modifications of Wnt genes by genistein during colon cancer development
Zhang, Y., Li, Q., & Chen, H. (2013) · Carcinogenesis · doi:10.1093/carcin/bgt129 · Cited by 79
The theoretical basis of cancer‐stem‐cell‐based therapeutics of cancer: can it be put into practice?
Sánchez-Garcı́a, I., Vicente‐Dueñas, C., & Cobaleda, C. (2007) · BioEssays · doi:10.1002/bies.20679 · Cited by 78
Zhang, Y., & Zheng, X.-F. (2012) · Cell Cycle · doi:10.4161/cc.11.3.19096 · Cited by 78
Uckun, F. M., Narla, R. K., Zeren, T., Yanishevski, Y., Myers, D. E., Waurzyniak, B. J., Ek, R. O., Schneider, E., Messinger, Y. H., Chelstrom, L. M., et al. (1998) · PubMed · Cited by 78
Androgen metabolism in prostate cancer: from molecular mechanisms to clinical consequences
Chang, K.-H., Ercole, C. E., & Sharifi, N. (2014) · British Journal of Cancer · doi:10.1038/bjc.2014.268 · Cited by 77
Nogueira, L., Ruiz-Ontañón, P., Vázquez-Barquero, A., Lafarga, M., Berciano, M. T., Aldaz, B., Grande, L., Casafont, Í., Segura, V., Robles, E. F., et al. (2011) · Oncogene · doi:10.1038/onc.2011.74 · Cited by 77
Warner, M. N., & Gustafsson, J.-Å. (2010) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2010.02.144 · Cited by 77
Wang, H., Li, Q., & Chen, H. (2012) · PLoS ONE · doi:10.1371/journal.pone.0040955 · Cited by 77
Leitch, A. E., Haslett, C., & Rossi, A. (2009) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2009.00402.x · Cited by 77
Bos, R., van Diest, P. J., van der Groep, P., Shvarts, A., Greijer, A. E., & van der Wall, E. (2004) · Breast Cancer Research · doi:10.1186/bcr813 · Cited by 77
Tyagi, A., Gu, M., Takahata, T., Frederick, B. A., Agarwal, C., Siriwardana, S., Agarwal, R., & Sclafani, R. A. (2011) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-11-1072 · Cited by 76
Advances in the treatment of ovarian cancer: a potential role of antiinflammatory phytochemicals.
Chen, S. S., Michael, A., & Butler-Manuel, S. A. (2012) · PubMed · Cited by 76
Self-citationResveratrol and aspirin eliminate tetraploid cells for anticancer chemoprevention
Lissa, D., Senovilla, L., Rello‐Varona, S., Vitale, I., Michaud, M., Pietrocola, F., Boilève, A., Obrist, F., Bordenave, C., Garcia, P., et al. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1318440111 · Cited by 74
Johnson, G. E., Ivanov, V. N., & Hei, T. K. (2008) · APOPTOSIS · doi:10.1007/s10495-008-0212-y · Cited by 74
Activation of Wnt/β-Catenin Signaling Increases Apoptosis in Melanoma Cells Treated with Trail
Zimmerman, Z. F., Kulikauskas, R. M., Bomsztyk, K., Moon, R. T., & Chien, A. J. (2013) · PLoS ONE · doi:10.1371/journal.pone.0069593 · Cited by 74
Nakamura, H., Wang, Y., Kurita, T., Adomat, H. H., Cunha, G. R., & Wang, Y. Z. (2011) · PLoS ONE · doi:10.1371/journal.pone.0020034 · Cited by 74
Mastermind-like 1 (MamL1) and mastermind-like 3 (MamL3) are essential for Notch signaling in vivo
Oyama, T., Harigaya, K., Sasaki, N., Okamura, Y., Kokubo, H., Saga, Y., Hozumi, K., Suganami, A., Tamura, Y., Nagase, T., et al. (2011) · Development · doi:10.1242/dev.062802 · Cited by 74
Yoshida, S., Aihara, K., Ikeda, Y., Sumitomo-Ueda, Y., Uemoto, R., Ishikawa, K., Ise, T., Yagi, S., Iwase, T., Mouri, Y., et al. (2013) · Circulation · doi:10.1161/circulationaha.113.001533 · Cited by 73
Nadal‐Serrano, M., Pons, D. G., Sastre‐Serra, J., Blanquer-Rosselló, M. D. M., Roca, P., & Oliver, J. (2013) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2013.07.002 · Cited by 73
Wang, Z., & Chen, H. (2010) · PubMed · Cited by 71
Mahajna, J. A., Dotan, N., Zaidman, B.-Z., Petrova, R. D., & Wasser, S. P. (2008) · Nutrition and Cancer · doi:10.1080/01635580802379323 · Cited by 70
Self-citationShim, H.-Y., Park, J.-H., Paik, H., Nah, S.-Y., Kim, D. S. H. L., & Han, Y. S. (2007) · Anti-Cancer Drugs · doi:10.1097/cad.0b013e3280825573 · Cited by 70
Resveratrol‐induced apoptosis is enhanced in low pH environments associated with cancer
Shamim, U., Hanif, S., Albanyan, A., Beck, F. W. J., Bao, B., Wang, Z. P., Banerjee, S., Sarkar, F. H., Mohammad, R. M., Hadi, S. M., et al. (2011) · Journal of Cellular Physiology · doi:10.1002/jcp.22865 · Cited by 70
Self-citationCancer development induced by graded expression of Snail in mice
Pérez-Mancera, P. A., Pérez-Caro, M., González‐Herrero, I., Flores, T., Órfão, A., de Herreros, A. G., Gutiérrez‐Adán, A., Pintado, B., Sagrera, A. M. A. D. P., Sánchez‐Martín, M., et al. (2005) · Human Molecular Genetics · doi:10.1093/hmg/ddi373 · Cited by 70
Mutations in human glycine N-methyltransferase give insights into its role in methionine metabolism
Luka, Z., Cerone, R., Phillips, J. A., Mudd, H. S., & Wagner, C. (2001) · Human Genetics · doi:10.1007/s00439-001-0648-4 · Cited by 69
Androgen Receptor Signaling Regulates Cell Growth and Vulnerability to Doxorubicin in Bladder Cancer
Shiota, M., Takeuchi, A., Yokomizo, A., Kashiwagi, E., Tatsugami, K., Kuroiwa, K., & Naito, S. (2012) · The Journal of Urology · doi:10.1016/j.juro.2012.02.2554 · Cited by 69
Wang, Y., Liu, Y., Lu, J., Zhang, P., Wang, Y., Xu, Y., Wang, Z., Mao, J.-H., & Wei, G. (2013) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2013.03.077 · Cited by 69
The role of the insulin-like growth factor-I receptor in malignancy: An update
Seccareccia, E., & Brodt, P. (2012) · Growth Hormone & IGF Research · doi:10.1016/j.ghir.2012.09.003 · Cited by 69
Vanamala, J., Radhakrishnan, S., Reddivari, L., Bhat, V. B., & Ptitsyn, A. A. (2011) · Proteome Science · doi:10.1186/1477-5956-9-49 · Cited by 69
Mardis, E. R. (2012) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2012.03.005 · Cited by 69
Tomellini, E., Touil, Y. S., Lagadec, C. H., Julien, S., Ostyn, P., Gelus, N., Meignan, S., Lengrand, J., Adriaenssens, É., Polakowska, R. R., et al. (2014) · Stem Cells · doi:10.1002/stem.1849 · Cited by 69
Bafilomycin A1 inhibits autophagy and induces apoptosis in MG63 osteosarcoma cells
Xie, Z., Xie, Y., Xu, Y., Zhou, H., Xu, W., & Dong, Q. (2014) · Molecular Medicine Reports · doi:10.3892/mmr.2014.2281 · Cited by 68
Potential Targets for Colorectal Cancer Prevention
Temraz, S. N., Mukherji, D., & Shamseddine, A. I. (2013) · International Journal of Molecular Sciences · doi:10.3390/ijms140917279 · Cited by 66
Bendinelli, P., Maroni, P., Matteucci, E., Luzzati, A., Perrucchini, G. G., & Desiderio, M. A. (2013) · European Journal of Cancer · doi:10.1016/j.ejca.2013.03.002 · Cited by 66
Marconett, C. N., Sundar, S. N., Tseng, M., Tin, A. S., Tran, K. Q., Mahuron, K. M., Bjeldanes, L. F., & Firestone, G. L. (2011) · Carcinogenesis · doi:10.1093/carcin/bgr116 · Cited by 66
The Role of Wnt Signaling In Cancer and Stem Cells
Reguart, N., He, B., Tarón, M., You, L., Jablons, D. M., & Rosell, R. (2005) · Future Oncology · doi:10.2217/14796694.1.6.787 · Cited by 66
Panchal, H. D., VRANIZAN, K. M., Lee, C. Y., Ho, J., Ngai, J., & Timiras, P. S. (2008) · Neurochemical Research · doi:10.1007/s11064-008-9608-x · Cited by 65
Choi, E. J., Jung, J. Y., & Kim, G. (2014) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2014.1771 · Cited by 65
Liu, X., Allen, J. D., Arnold, J. T., & Blackman, M. R. (2008) · Carcinogenesis · doi:10.1093/carcin/bgn011 · Cited by 65
Agarwal, C., Dhanalakshmi, S., Singh, R. P., & Agarwal, R. (2004) · Neoplasia · doi:10.1593/neo.04232 · Cited by 64
Salpeter, S. J., Klochendler, A., Weinberg-Corem, N., Porat, S., Granot, Z., Shapiro, A. M. J., Magnuson, M. A., Eden, A., Grimsby, J. S., Gläser, B., et al. (2011) · Endocrinology · doi:10.1210/en.2010-1372 · Cited by 64
Transcriptional Outcome of Wnt-Frizzled Signal Transduction in Inflammation: Evolving Concepts
Sen, M., & Ghosh, G. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.181.7.4441 · Cited by 64
Kang, N.-H., Hwang, K., Lee, H.-R., Choi, D.-W., & Choi, K. (2013) · Food and Chemical Toxicology · doi:10.1016/j.fct.2013.06.029 · Cited by 63
Selective elimination of leukemia stem cells: Hitting a moving target
Crews, L. A., & Jamieson, C. H. M. (2012) · Cancer Letters · doi:10.1016/j.canlet.2012.08.006 · Cited by 63
Regulation of self‐renewal in normal and cancer stem cells
Falzacappa, M. V. V., Ronchini, C., Reavie, L. B., & Pelicci, P. G. (2012) · FEBS Journal · doi:10.1111/j.1742-4658.2012.08727.x · Cited by 62
Genistein induces growth arrest and suppresses telomerase activity in brain tumor cells
Khaw, A. K., Yong, J. W. Y., Kalthur, G., & Hande, M. P. (2012) · Genes Chromosomes and Cancer · doi:10.1002/gcc.21979 · Cited by 62
Another Tie that Binds the MTA Family to Breast Cancer
Kumar, R. (2003) · Cell · doi:10.1016/s0092-8674(03)00274-5 · Cited by 61
Nutritional flavonoids impact on nuclear and extranuclear estrogen receptor activities
Galluzzo, P., & Marino, M. (2006) · Genes & Nutrition · doi:10.1007/bf02829966 · Cited by 61
Self-citationNatural products as potential cancer therapy enhancers: A preclinical update
Agbarya, A., Ruimi, N., Epelbaum, R., Ben‐Arye, E., & Mahajna, J. A. (2014) · SAGE Open Medicine · doi:10.1177/2050312114546924 · Cited by 61
Self-citationCurcumin inhibits hypoxia-induced angiogenesis via downregulation of HIF-1
Kim, S.-R., Bae, S., Kim, K., & Bae, M. (2006) · Vascular Pharmacology · doi:10.1016/j.vph.2006.08.403 · Cited by 60
Criswell, T. L., & Arteaga, C. L. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m704434200 · Cited by 60
Jin, Q., Shen, H., Wang, H., Shou, Q., & Liu, Q. (2013) · Diabetology & Metabolic Syndrome · doi:10.1186/1758-5996-5-12 · Cited by 60
Smith, D. A., Kiba, A., Zong, Y., & Witte, O. N. (2013) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-13-0238 · Cited by 60
Resveratrol Targets Transforming Growth Factor-β2 Signaling to Block UV-Induced Tumor Progression
Kim, K. H., Back, J. H., Zhu, Y., Arbesman, J., Athar, M., Kopelovich, L., Kim, A. L., & Bickers, D. R. (2010) · Journal of Investigative Dermatology · doi:10.1038/jid.2010.250 · Cited by 59
Rapamycin inhibits oncogenic intestinal ion channels and neoplasia in APCMin/+ mice
Koehl, G. E., Spitzner, M., Ousingsawat, J., Schreiber, R., Geissler, E. K., & Kunzelmann, K. (2009) · Oncogene · doi:10.1038/onc.2009.435 · Cited by 59
Chemoprevention with Phytonutrients and Microalgae Products in Chronic Inflammation and Colon Cancer
Talero, E., Ávila‐Román, J., & Motilva, V. (2012) · Current Pharmaceutical Design · doi:10.2174/138161212802083725 · Cited by 59
Wang, S.-D., Chen, B.-C., Kao, S.-T., Liu, C.-J., & Yeh, C.-C. (2014) · BMC Complementary and Alternative Medicine · doi:10.1186/1472-6882-14-26 · Cited by 59
Sehrawat, A., Arlotti, J. A., Murakami, A., & Singh, S. V. (2012) · Breast Cancer Research and Treatment · doi:10.1007/s10549-012-2280-5 · Cited by 58
Chemoprevention of head and neck squamous cell carcinoma through inhibition of NF-κB signaling
Broek, R. V., Snow, G. E., Chen, Z., & Waes, C. V. (2013) · Oral Oncology · doi:10.1016/j.oraloncology.2013.10.005 · Cited by 57
Léotoing, L., Manin, M., Monté, D., Baron, S., Communal, Y., Lours-Calet, C., VEYSSIERE, G., Morel, L., & Beaudoin, C. (2007) · Journal of Molecular Endocrinology · doi:10.1677/jme-07-0021 · Cited by 57
Insulin-Like Growth Factor I Stimulates Telomerase Activity in Prostate Cancer Cells
Wetterau, L. A., Francis, M. J., Ma, L., & Cohen, P. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2002-021326 · Cited by 56
A new role for NF-κB in angiogenesis inhibition
Tabruyn, S. P., & Griffioen, A. W. (2007) · Cell Death and Differentiation · doi:10.1038/sj.cdd.4402156 · Cited by 56
Salim, T., Sand‐Dejmek, J., & Sjölander, A. (2013) · Experimental Cell Research · doi:10.1016/j.yexcr.2013.10.021 · Cited by 56
Bishayee, A., Thoppil, R. J., Darvesh, A. S., Ohanyan, V. A., Meszaros, J. G., & Bhatia, D. (2012) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2012.04.009 · Cited by 56
Listerman, I., Gazzaniga, F. S., & Blackburn, E. H. (2013) · Molecular and Cellular Biology · doi:10.1128/mcb.00844-13 · Cited by 56
Kwon, J., Joung, H., Kim, Y. S., et al. (2012) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2012.07.040 · Cited by 56
Palozza, P., Sheriff, A., Serini, S., Boninsegna, A., Maggiano, N., Ranelletti, F. O., Calviello, G., & Cittadini, A. R. M. (2005) · APOPTOSIS · doi:10.1007/s10495-005-1393-2 · Cited by 55
The Anti-Cancer Charm of Flavonoids: A Cup-of-Tea Will Do!
Amin, A., & Buratovich, M. (2007) · Recent Patents on Anti-Cancer Drug Discovery · doi:10.2174/157489207780832414 · Cited by 55
Self-citationBurgess, L. C., Rice, E., Fischer, T., Seekins, J. R., Burgess, T. P., Sticka, S. J., & Klatt, K. (2008) · Toxicology in Vitro · doi:10.1016/j.tiv.2008.03.001 · Cited by 55
Zhang, C., Yang, N., Yang, C., Ding, H., Luo, C., Zhang, Y., Wu, M., Zhang, X., Shen, X., Jiang, H., et al. (2009) · PLoS ONE · doi:10.1371/journal.pone.0004881 · Cited by 55
Bose, M., Hao, X., Ju, J., Husain, A., Park, S., Lambert, J. D., & Yang, C. S. (2007) · Journal of Agricultural and Food Chemistry · doi:10.1021/jf071004r · Cited by 53
Lycopene Effects Contributing to Prostate Health
Wertz, K. (2009) · Nutrition and Cancer · doi:10.1080/01635580903285023 · Cited by 53
Effect of NF-κB Signaling on Apoptosis in Chronic Inflammation-Associated Carcinogenesis
Wang, H., & Cho, C. H. (2010) · Current Cancer Drug Targets · doi:10.2174/156800910791859425 · Cited by 53
SU5416 inhibited VEGF and HIF-1α expression through the PI3K/AKT/p70S6K1 signaling pathway
Zhong, X., Zheng, J. Z., Reed, E., & Jiang, B. (2004) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2004.09.082 · Cited by 52
Bhatia, D., Thoppil, R. J., Mandal, A., Samtani, K., Darvesh, A. S., & Bishayee, A. (2013) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2013/371813 · Cited by 51
Curcumin suppresses HIF1A synthesis and VEGFA release in pituitary adenomas
Shan, B., Schaaf, C. P., Schmidt, A., Lucia, K. E., Buchfelder, M., Losa, M., Kuhlen, D., Kreutzer, J., Perone, M. J., ARZT, E. S., et al. (2012) · Journal of Endocrinology · doi:10.1530/joe-12-0207 · Cited by 51
Ren, Z., Chen, X., Cui, G., Yin, S., Chen, L., Jiang, J., Hu, Z., Xie, H., Zheng, S., & Zhou, L. (2013) · PLoS ONE · doi:10.1371/journal.pone.0074322 · Cited by 50
Marconett, C. N., Singhal, A. K., Sundar, S. N., & Firestone, G. L. (2012) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2012.07.008 · Cited by 49
Naringenin and 17β‐estradiol coadministration prevents hormone‐induced human cancer cell growth
Bulzomi, P., Bolli, A., Galluzzo, P., Leone, S., Acconcia, F., & Marino, M. (2009) · IUBMB Life · doi:10.1002/iub.279 · Cited by 49
Self-citationHeeg, S., Hirt, N., Queisser, A., Schmieg, H., Thaler, M., Kunert, H., Quante, M., Goessel, G., von Werder, A., Harder, J., et al. (2010) · Cancer Science · doi:10.1111/j.1349-7006.2010.01796.x · Cited by 49
Denissova, N. G., Nasello, C., Yeung, P. L., Tischfield, J. A., & Brenneman, M. A. (2011) · Carcinogenesis · doi:10.1093/carcin/bgr236 · Cited by 48
Axanova, L. S., Chen, Y. Q., McCoy, T. P., Sui, G., & Cramer, S. D. (2010) · The Prostate · doi:10.1002/pros.21201 · Cited by 48
Autophagy: an adaptable modifier of tumourigenesis.
Wilkinson, S., & Ryan, K. (2010) · Current Opinion in Genetics and Development · doi:10.1016/j.gde.2009.12.004 · Cited by 48
Importance of Wnt Signaling in the Tumor Stroma Microenvironment
Macheda, M. L., & Stacker, S. A. (2008) · Current Cancer Drug Targets · doi:10.2174/156800908785699324 · Cited by 48
Zhou, C., Steplowski, T. A., Dickens, H. K., Malloy, K., Gehrig, P. A., Boggess, J. F., & Bae-Jump, V. L. (2013) · PLoS ONE · doi:10.1371/journal.pone.0055730 · Cited by 48
Phytoestrogens induce apoptosis through a mitochondria/caspase pathway in human breast cancer cells
Chen, F., & Chien, M. (2013) · Climacteric · doi:10.3109/13697137.2013.869671 · Cited by 48
Li, S., Wang, N., & Brodt, P. (2011) · Cancer Research · doi:10.1158/0008-5472.can-11-1357 · Cited by 48
Resveratrol Prevents Dendritic Cell Maturation in Response to Advanced Glycation End Products
Buttari, B., Profumo, E., Facchiano, F., Ozturk, E. I., Segoni, L., Saso, L., & Riganò, R. (2013) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2013/574029 · Cited by 48
Research works printed but not linked: 51
- Wang, 2013, SLUG is activated by nuclear factor kappa B and confers human alveolar epithelial A549 cells resistance to tumor necrosis factor-alpha-induced apoptosis, World J Surg Oncol, 11, 12, 10.1186/1477-7819-11-12 · doi:10.1186/1477-7819-11-12
- Hede, 2006, PTEN takes center stage in cancer stem cell research, works as tumor suppressor, J Natl Cancer Inst, 98, 808, 10.1093/jnci/djj270 · doi:10.1093/jnci/djj270
- Hamburger, 1977, Primary bioassay of human myeloma stem cells, J Clin Invest, 60, 846, 10.1172/JCI108839 · doi:10.1172/jci108839
- Sánchez-García, 2009, The crossroads of oncogenesis and metastasis, N Engl J Med, 360, 297, 10.1056/NEJMcibr0808031 · doi:10.1056/nejmcibr0808031
- Tomellini, 2014, NGF and proNGF simultaneously promote symmetric self-renewal, quiescence and EMT to enlarge the breast cancer stem cell compartment, Stem Cells
- Tamari, 2014, Identification of chemoradiation-resistant osteosarcoma stem cells using an imaging system for proteasome activity, Int J Oncol, 45, 2349, 10.3892/ijo.2014.2671 · doi:10.3892/ijo.2014.2671
- Krishnan, 2013, Using MKK4's metastasis suppressor function to identify and dissect cancer cell-microenvironment interactions during metastatic colonization, Cancer Metastasis Rev, 31, 605, 10.1007/s10555-012-9371-y · doi:10.1007/s10555-012-9371-y
- Fang, 2011, Imatinib plus granulocyte colony-stimulating factor in chronic myeloid leukemia patients who have achieved partial or complete cytogenetic response while on Imatinib, Case Rep Oncol, 4, 192, 10.1159/000327512 · doi:10.1159/000327512
- Danovi, 2008, Angiogenesis: turning it down a Notch, Nat Rev Cancer, 8, 572, 10.1038/nrc2448 · doi:10.1038/nrc2448
- Kakarala, 2007, Cancer stem cells: implications for cancer treatment and prevention, Cancer J, 13, 271, 10.1097/PPO.0b013e318156da4e · doi:10.1097/ppo.0b013e318156da4e
- Chen, 1997, Regulation of the ERBB-2 promoter by RBPJк and NOTCH, J Biol Chem, 272, 14110, 10.1074/jbc.272.22.14110 · doi:10.1074/jbc.272.22.14110
- Ghayad, 2010, Inhibitors of the PI3K/Akt/mTOR pathway: new hope for breast cancer patients, Recent Pat Anticancer Drug Discov, 5, 29, 10.2174/157489210789702208 · doi:10.2174/157489210789702208
- Jeng, 2012, Blockade of the sonic hedgehog pathway effectively inhibits the growth of hepatoma in mice: an in vivo study, Oncology Lett, 4, 1158, 10.3892/ol.2012.935 · doi:10.3892/ol.2012.935
- Kinsell, 1948, Studies in methionine and sulfur metabolism. I. The fate of intravenously administered methionine in normal individuals and in patients with liver damage, J Clin Invest, 27, 677, 10.1172/JCI102016 · doi:10.1172/jci102016
- Mintz, 2008, The phosphorylated membrane estrogen receptor and cytoplasmic signaling and apoptosis proteins in human breast cancer, Cancer, 113, 1489, 10.1002/cncr.23699 · doi:10.1002/cncr.23699
- Bolli, 2011, Current and future development of estrogen receptor ligands: applications in estrogen-related cancers, Recent Pat Endocr Metab Immune Drug Discov, 5, 210, 10.2174/187221411797265881 · doi:10.2174/187221411797265881
- Pedersen, 2005, Differential response to gefitinib of cells expressing normal EGFR and the mutant EGFRvIII, Br J Cancer, 93, 915, 10.1038/sj.bjc.6602793 · doi:10.1038/sj.bjc.6602793
- Kuhad, 2007, Effect of curcumin on inflammation and oxidative stress in cisplatin-induced experimental nephrotoxicity, J Agric Food Chem, 55, 10150, 10.1021/jf0723965 · doi:10.1021/jf0723965
- Izutani, 2012, Brassinin induces G1 phase arrest through increase of p21 and p27 by inhibition of the phosphatidylinositol 3-kinase signaling pathway in human colon cancer cells, Int J Oncol, 40, 816
- Wen, 2010, Preparation and physicochemical properties of the complex of naringenin with hydroxypropyl-β-cyclodextrin, Molecules, 15, 4401, 10.3390/molecules15064401 · doi:10.3390/molecules15064401
- Choi, 2004, Kim YC Enhanced paclitaxel bioavailability after oral administration of paclitaxel or prodrug to rats pretreated with quercetin, Eur J Pharm Biopharm, 57, 313, 10.1016/j.ejpb.2003.11.002 · doi:10.1016/j.ejpb.2003.11.002
- Kanadzu, 2006, Dual function of epigallocatechin gallate (EGCG) in healthy human lymphocytes, Cancer Lett, 241, 250, 10.1016/j.canlet.2005.10.021 · doi:10.1016/j.canlet.2005.10.021
- Parker, 2009, Modulation of microRNA associated with ovarian cancer cells by genistein, Eur J Gynaecol Oncol, 30, 616
- Park, 2010, Combined cetuximab and genistein treatment shows additive anti-cancer effect on oral squamous cell carcinoma, Cancer Lett, 292, 54, 10.1016/j.canlet.2009.11.004 · doi:10.1016/j.canlet.2009.11.004
- Mills, 1989, Cohort study of diet, lifestyle, and prostate cancer in Adventist men, Cancer, 64, 598, 10.1002/1097-0142(19890801)64:3<598::AID-CNCR2820640306>3.0.CO;2-6 · doi:10.1002/1097-0142(19890801)64:3<598::aid-cncr2820640306>3.0.co;2-6
- Giovannucci, 2007, Does prostate-specific antigen screening influence the results of studies of tomatoes, lycopene, and prostate cancer risk?, J Natl Cancer Inst, 99, 1060, 10.1093/jnci/djm048 · doi:10.1093/jnci/djm048
- Choi, 2004, Enhanced paclitaxel bioavailability after oral administration of paclitaxel or prodrug to rats pretreated with quercetin, Eur J Pharm Biopharm, 57, 313, 10.1016/j.ejpb.2003.11.002 · doi:10.1016/j.ejpb.2003.11.002
- Guruvayoorappan, 2008, 13 cis-retinoic acid regulates cytokine production and inhibits angiogenesis by disrupting endothelial cell migration and tube formation, J Exp Ther Oncol, 7, 173
- Zaidman, 2008, Coprinus comatus and Ganoderma lucidum interfere with androgen receptor function in LNCaP prostate cancer cells, Mol Biol Rep, 35, 107, 10.1007/s11033-007-9059-5 · doi:10.1007/s11033-007-9059-5
- Zhang, 2011, Genistein attenuates WNT signaling by up-regulating sFRP2 in a human colon cancer cell line, Exp Biol Med (Maywood), 236, 714, 10.1258/ebm.2011.010347 · DOI
- Abdelwahab, 2011, Zerumbone induces apoptosis in T-acute lymphoblastic leukemia cells, Leuk Res, 35, 268, 10.1016/j.leukres.2010.07.025 · doi:10.1016/j.leukres.2010.07.025
- Tang, 2010, (−)-Epigallocatechin3-gallate induces apoptosis and suppresses proliferation by inhibiting the human Indian Hedgehog pathway in human chondrosarcoma cells, J Cancer Res Clin Oncol, 136, 1179, 10.1007/s00432-010-0765-3 · doi:10.1007/s00432-010-0765-3
- Cheng, 2011, Novel agents for the treatment of pancreatic adenocarcinoma, JOP, 12, 334
- Huynh, 2003, Inhibition of ErbB-2 and ErbB-3 expression by quercetin prevents transforming growth factor alpha (TGF-alpha)- and epidermal growth factor (EGF)-induced human PC-3 prostate cancer cell proliferation, Int J Oncol, 23, 821
- Pratheeshkumar, 2012, Quercetin inhibits angiogenesis mediated human prostate tumor growth by targeting VEGFR-2 regulated AKT/mTOR/P70S6K signaling pathways, PLoS ONE, 7, e47516, 10.1371/journal.pone.0047516 · DOI · Paper page
- Chen, 2013, Modeling the estrogen receptor to growth factor receptor signaling switch in human breast cancer cells, FEBS Lett, 587, 3327, 10.1016/j.febslet.2013.08.022 · doi:10.1016/j.febslet.2013.08.022
- Gabellini, 2013, BH4 domain of bcl-2 protein is required for its proangiogenic function under hypoxic condition, Carcinogenesis, 34, 2558, 10.1093/carcin/bgt242 · doi:10.1093/carcin/bgt242
- Wang, 2013, Targeting mixed lineage kinases in ER-positive breast cancer cells leads to G2/M cell cycle arrest and apoptosis, Oncotarget, 4, 1158, 10.18632/oncotarget.1093 · doi:10.18632/oncotarget.1093
- Nishinakagawa, 2010, Analysis of cell cycle arrest and apoptosis induced by RCAS1, Int J Mol Med, 25, 717
- Wong, 2009, Induction of proinflammatory response in prostate cancer epithelial cells by activated macrophages, Cancer Lett, 276, 38, 10.1016/j.canlet.2008.10.025 · doi:10.1016/j.canlet.2008.10.025
- Maeyama, 2011, Intracellular estrogen receptor-binding fragment-associated antigen 9 exerts in vivo tumor-promoting effects via its coiled-coil region, Int J Oncol, 39, 41
- Peretz, 2002, IGF1 receptor expression protects against microenvironmental stress found in the solid tumor, Radiat Res, 158, 174, 10.1667/0033-7587(2002)158[0174:IREPAM]2.0.CO;2 · doi:10.1667/0033-7587(2002)158[0174:irepam]2.0.co;2
- Dorai, 2000, Therapeutic potential of curcumin in human prostate cancer-I. curcumin induces apoptosis in both androgen-dependent and androgen independent prostate cancer cells, Prostate Cancer Prostatic Dis, 3, 84, 10.1038/sj.pcan.4500399 · doi:10.1038/sj.pcan.4500399
- Park, 2002, Curcumin inhibits cell cycle progression of immortalized human umbilical vein endothelial (ECV304) cells by up-regulating cyclin-dependent kinase inhibitor, p21WAF1/CIP1, p27KIP1 and p53, Int J Oncol, 21, 379
- Nakamura, 2012, Genistein inhibits cell invasion and motility by inducing cell differentiation in murine osteosarcoma cell line LM8, BMC Cell Biol, 13, 24, 10.1186/1471-2121-13-24 · doi:10.1186/1471-2121-13-24
- Yu, 2011, Curcumin reverses chemoresistance of human gastric cancer cells by downregulating the NF-κB transcription factor, Oncol Rep, 26, 1197
- Chen, 2011, Anti-proliferative and anti-metastatic effects of curcumin on oral cancer cells, Hua Xi Kou Qiang Yi Xue Za Zhi, 29, 83
- Mendivil, 2011, AMG 479, a novel IGF-1-R antibody, inhibits endometrial cancer cell proliferation through disruption of the PI3K/Akt and MAPK pathways, Reprod Sci, 18, 832, 10.1177/1933719111398501 · doi:10.1177/1933719111398501
- Sayeed, 2013, Aberrant regulation of the BST2 (Tetherin) promoter enhances cell proliferation and apoptosis evasion in high grade breast cancer cells, PLoS ONE, 8, e67191, 10.1371/journal.pone.0067191 · doi:10.1371/journal.pone.0067191
- Breen, 2013, Endoglin-mediated suppression of prostate cancer invasion is regulated by activin and bone morphogenetic protein type II receptors, PLoS ONE, 8, e72407, 10.1371/journal.pone.0072407 · doi:10.1371/journal.pone.0072407
- Bryant, 2010, Reduction of hypoxia-induced angiogenesis in ovarian cancer cells by inhibition of HIF-1 alpha gene expression, Arch Gynecol Obstet, 282, 677, 10.1007/s00404-010-1381-9 · doi:10.1007/s00404-010-1381-9
Cited by
Metabolomics for Investigating Physiological and Pathophysiological Processes
Wishart, D. S. (2019) · Physiological Reviews · doi:10.1152/physrev.00035.2018 · Cited by 1,212
Effect of exosomal miRNA on cancer biology and clinical applications
Sun, Z., Shi, K., Yang, S., Liu, J., Zhou, Q., Wang, G., Song, J., Li, Z., Zhang, Z., & Yuan, W. (2018) · Molecular Cancer · doi:10.1186/s12943-018-0897-7 · Cited by 800
Ageing, Cellular Senescence and Neurodegenerative Disease
Kritsilis, M., V. Rizou, S., Koutsoudaki, P. N., Evangelou, K., Gorgoulis, V. G., & Papadopoulos, D. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19102937 · Cited by 448
Gan, R.-Y., Li, H.-B., Sui, Z.-Q., & Corke, H. (2018) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2016.1231168 · Cited by 438
Therapeutic potential of targeting the Wnt/β-catenin signaling pathway in colorectal cancer
Cheng, X., Xu, X., Chen, D., Zhao, F., & Wang, W. (2019) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2018.11.082 · Cited by 417
Metadata
- Authors
- Feitelson, M. A., Arzumanyan, A., Kulathinal, R. J., Blain, S. W., Holcombe, R. F., Mahajna, J., Marino, M., Martinez-Chantar, M. L., Nawroth, R., Sanchez-Garcia, I., Sharma, D., Saxena, N. K., Singh, N., Vlachostergios, P. J., Guo, S., Honoki, K., Fujii, H., Georgakilas, A. G., Bilsland, A., Amedei, A., Niccolai, E., Amin, A., Ashraf, S. S., Boosani, C. S., Guha, G., Ciriolo, M. R., Aquilano, K., Chen, S., Mohammed, S. I., Azmi, A. S., Bhakta, D., Halicka, D., Keith, W. N., & Nowsheen, S.
- Venue
- Seminars in Cancer Biology
- Publisher
- Elsevier BV
- Published
- 2015-12
- Volume
- 35
- Pages
- S25-S54
- ISSN
- 1044-579X (ISSN-L)
- OpenAlex
- W2026982091
- Cited by
- 778
- References
- 671
- FWCI
- 10.66
- Type
- journal article
- Language
- en
- Open access
- hybrid
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- www.elsevier.com/legal/tdmrep-license (tdm)
- creativecommons.org/licenses/by-nc-nd/4.0/ (vor)
- Funders
- European Commission (MC-CIG-303514)
- Associazione Italiana per la Ricerca sul Cancro (IG15221, 10636)
- National Institutes of Health (AI076535)
- University of Glasgow
- National Science Foundation
- Purdue University Center for Cancer Research
- Avon Foundation for Women
- Cancer Research UK (C301/A14762)
- Ministero dell’Istruzione, dell’Università e della Ricerca (20125S38FA_002)
- European Cooperation in Science and Technology (CM1201)
- Ministero della Salute (GR-2011-02348047)
- Breast Cancer Research Foundation (K01DK077137, 90047965, R03DK089130, SR/FT/LS-063/2008)
- Seventh Framework Programme (CA155686, R01CA131294)
- Al Jalila Foundation (AJF201454)
- Ministry of Education, Culture, Sports, Science and Technology (24590493)
- European Regional Development Fund
- Ministerio de Ciencia e Innovación (SAF2012-32810, R01 CA109335-04A1)
- Università degli Studi Roma Tre (CLA 2013)
- Consejería de Educación, Junta de Castilla y León (BIO/SA06/13, FP7-ENV-2011)
- American Cancer Society
- Temple University
- Terry Fox Foundation (TF-36)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.